Related Experiment Video
Updated: Feb 10, 2026

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
Company Profile: Multiple Myeloma Research Foundation
1Multiple Myeloma Research Foundation (MMRF) & the Multiple Myeloma Research Consortium (MMRC), Norwalk, CT, USA. giustik@themmrf.org.
Abstract:
The role of nonprofit organizations in drug development has evolved from a primary emphasis on grant funding to a driving force that is advancing scientific development and leading cutting edge research. The Multiple Myeloma Research Foundation (MMRF) is a leader in this field, and has recognized that despite recent advances, multiple myeloma patients' responses to today's treatments are variable and unpredictable, often based on the patient's molecular profile. The MMRF believes all patients would benefit from the creation of new, personalized treatment approaches and is working to make this vision a reality with its ambitious Personalized Medicine Initiative. Most recently, MMRF launched the CoMMpassSM (Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile) study to collect and analyze tissue samples and genetic information from approximately 1000 multiple myeloma patients over the next 5 years. The study is designed to tailor next-generation personalized multiple myeloma treatments.
Related Concept Videos
Social Foundations of Self II: The Generalized Other
Physiological Foundation of Stress
Role of the Sympathetic Nervous System
Adrenaline triggers the...
Theoretical Foundations of Nursing Practice
Theories provide a perspective to assess patients' conditions and organize data and methods. They also assist in analyzing and interpreting information. They represent a...
Social Foundations of Self I: Play and Game
Social Foundations of Self III: Self-Evaluation
Social Foundations of Self IV: Self in Digital Communication

